Preemptive Meds Private Limited
Founded in 2011 and headquartered in Kerala, India.
2011 | Kottayam, Kerala (India) | Active
Preemptive Meds Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.20 M
- Revenue Growth 860.08%
- Profit Growth 2521.35%
- Ebitda 1389.47%
- Net Worth 39.77%
- Total Assets 53.87%
About Preemptive Meds
Preemptive Meds Private Limited (PMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2011 and has a history of 13 years and five months. Its registered office is in Kottayam, Kerala, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.20 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jessy George, George Fenn, and Joe Fenn serve as directors at the Company.
Company Details
- Location
Kottayam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100KL2011PTC029481
- Company No.
029481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Business Services
Professional Services
Who are the key members and board of directors at Preemptive Meds?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jessy George  | Director | 30-Sep-2011 | Current |
| George Fenn | Director | 30-Sep-2011 | Current |
Joe Fenn  | Director | 02-Dec-2019 | Current |
Financial Performance of Preemptive Meds.
Preemptive Meds Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 860.08% increase. The company also saw a substantial improvement in profitability, with a 2521.35% increase in profit. The company's net worth Soared by an impressive increase of 39.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Preemptive Meds?
In 2017, Preemptive Meds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pfoods Private Limited
Jessy George and Joe Fenn are mutual person
- Ncd Predisease Forum
George Fenn is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.20 M
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2019 | Others | ₹1.20 M | Satisfied |
How Many Employees Work at Preemptive Meds?
Unlock and access historical data on people associated with Preemptive Meds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Preemptive Meds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preemptive Meds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Preemptive Meds
Recent activity within the organization
- Annual General Meeting
Preemptive Meds Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge registered on 07 Nov 2019 via Charge ID 100302611 with Others was fully satisfied on 18 Apr 2024.
- Balance Sheet
Preemptive Meds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
- Director Appointment
Joe George Fenn was appointed as a Director was appointed as a Director on 02 Dec 2019 & has been associated with this company since 5 years 3 months .
- Charges
A charge with Others amounted to Rs. 1.20 M with Charge ID 100302611 was registered on 07 Nov 2019.
- Director Appointment
Jessy Fenn George was appointed as a Director was appointed as a Director on 30 Sep 2011 & has been associated with this company since 13 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Preemptive Meds Private Limited?
Preemptive Meds Private Limited was incorporated on 30 Sep 2011.
What is authorized share capital and paid-up capital of Preemptive Meds Private Limited?
The authorized share capital of Preemptive Meds Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Preemptive Meds Private Limited?
Currently 3 directors are associated with Preemptive Meds Private Limited.
- Jessy Fenn George
- George Fenn
- Joe George Fenn
What is the registered address of Preemptive Meds Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Preemptive Meds Private Limited is Thoppil House Vazhoor Post India, Kottayam, Kerala, 686504.
What is the corporate identification number (CIN) and company number of Preemptive Meds Private Limited?
The corporate identification number (CIN) of Preemptive Meds Private Limited is U24100KL2011PTC029481 and the company number is 029481 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Preemptive Meds Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Preemptive Meds Private Limited has risen by 860.08%.
What change has been observed in the net worth of Preemptive Meds Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Preemptive Meds Private Limited has experienced an upsurge of 39.77%.
When was the last Balance Sheet of Preemptive Meds Private Limited filed with the ROC?
The most recent Balance Sheet for Preemptive Meds Private Limited was filed with the ROC on 31 Mar 2024.